
// DOCENTE OCASIONAL //
Maestría en Ingeniería de Sistemas y Computación
pregrado
Ingeniero Electrónico

// DOCENTE OCASIONAL //
Maestría en Ingeniería de Sistemas y Computación
pregrado
Ingeniero Electrónico
Diflucan can increase phenytoin levels, risking toxicity.
Diflucan is used in the management of some cases of chronic disseminated candidiasis.
The high oral bioavailability of Diflucan makes it exceptionally convenient for outpatient step-down therapy.
Concomitant use with calcium channel blockers can lead to excessive hypotension and edema.
Diflucan's role has been defined by large, randomized controlled trials in HIV and ICU populations.
Alopecia is a reversible but distressing side effect reported with prolonged use.
The long half-life (~30 hours) enables convenient once-daily dosing regimens.
Therapeutic drug monitoring for Diflucan is not routine but can guide therapy in complex cases.
Breakthrough infections during prophylaxis are a significant clinical red flag.
Therapeutic success relies heavily on host immune status and source control.